2026 Philip A. Starr: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	79	1673	1524	818	727	321	24650
Medicine	79	17493	16439	8757	8091	320	24579

Overview

Philip A. Starr is affiliated with the University of California, San Francisco in the United States. Their research spans multiple facets of medicine and neuroscience, with a focus on neurology and cellular and molecular neuroscience.

The main fields of study include:

Medicine
Neuroscience

Their subfields of study highlight specialized interests in:

Neurology
Cellular and Molecular Neuroscience
Cognitive Neuroscience
Radiology, Nuclear Medicine and Imaging
Clinical Psychology

Philip A. Starr's research covers several main topics across neurological and neural engineering disciplines. Key topics of their work include:

Neurological disorders and treatments
Neuroscience and Neural Engineering
Parkinson's Disease Mechanisms and Treatments
EEG and Brain-Computer Interfaces
Transcranial Magnetic Stimulation Studies
Genetic Neurodegenerative Diseases
Functional Brain Connectivity Studies

Frequent co-authors collaborating with Philip A. Starr are:

Simon Little
Jill L. Ostrem
Doris D. Wang
Ro'ee Gilron
Edward F. Chang

The scientist has published extensively in various academic venues. The most frequent publication venues include:

bioRxiv (Cold Spring Harbor Laboratory)
Brain stimulation
Frontiers in Human Neuroscience
Frontiers in Neuroscience
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Recent publications by Philip A. Starr include:

Closed-loop neuromodulation in an individual with treatment-resistant depression, 2021, Nature Medicine
Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease, 2021, Nature Biotechnology
Prefrontal-Subthalamic Hyperdirect Pathway Modulates Movement Inhibition in Humans, 2020, Neuron
Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson's disease: a blinded randomized feasibility trial, 2024, Nature Medicine
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study, 2020, The Lancet Neurology

Best Publications

Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Kenneth A. Follett;Kenneth A. Follett;Frances M. Weaver;Matthew Stern;Kwan Hur

1572
Citations
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J Marks;Jill L Ostrem;Leonard Verhagen;Philip A Starr

816
Citations
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

William J Marks;Raymond T Bartus;Joao Siffert;Charles S Davis

749
Citations
Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease

Coralie de Hemptinne;Nicole C Swann;Jill L Ostrem;Elena S Ryapolova-Webb

675
Citations
Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations.

Philip A. Starr;Chadwick W. Christine;Philip V. Theodosopoulos;Nadja Lindsey

658
Citations
Exaggerated phase–amplitude coupling in the primary motor cortex in Parkinson disease

Coralie de Hemptinne;Elena S. Ryapolova-Webb;Ellen L. Air;Paul A. Garcia

598
Citations
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

Frances M. Weaver;Frances M. Weaver;Kenneth A. Follett;Matthew B. Stern;Matthew B. Stern;Ping Luo

561
Citations
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

C. W. Christine;P. A. Starr;P. S. Larson;J. L. Eberling

505
Citations
Closed-loop neuromodulation in an individual with treatment-resistant depression.

Katherine W. Scangos;Katherine W. Scangos;Ankit N. Khambhati;Ankit N. Khambhati;Patrick M. Daly;Patrick M. Daly;Ghassan S. Makhoul;Ghassan S. Makhoul

469
Citations
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

J. L. Eberling;W. J. Jagust;C. W. Christine;P. Starr

426
Citations
Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease

Jerrold L. Vitek;Roy A. E. Bakay;Takao Hashimoto;Yoshiki Kaneoke

395
Citations
Adaptive deep brain stimulation for Parkinson's disease using motor cortex sensing.

Nicole C Swann;Coralie de Hemptinne;Margaret C Thompson;Svjetlana Miocinovic

387
Citations
Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes.

Philip A. Starr;Robert S. Turner;Geoff Rau;Nadja Lindsey

367
Citations
Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation.

Hazem A. Eltahawy;Jean Saint-Cyr;Nir Giladi;Anthony E. Lang

364
Citations
Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates.

Thomas Wichmann;Hagai Bergman;Philip A. Starr;Thyagarajan Subramanian

363
Citations
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.

Gabriele Mittermeyer;Chadwick W. Christine;Kathryn H. Rosenbluth;Suzanne L. Baker

336
Citations
Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders.

Devin K. Binder;Geoff M. Rau;Philip A. Starr

328
Citations
Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease

Nicole C. Swann;Coralie de Hemptinne;Svjetlana Miocinovic;Salman Qasim

323
Citations
Beta Oscillations in Working Memory, Executive Control of Movement and Thought, and Sensorimotor Function

Robert Schmidt;Maria Herrojo Ruiz;Maria Herrojo Ruiz;Bjørg E. Kilavik;Mikael Lundqvist

320
Citations
Porcine Xenografts in Parkinson's Disease and Huntington's Disease Patients: Preliminary Results:

J S Fink;J M Schumacher;S L Ellias;E P Palmer

313
Citations
Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease.

Ro’ee Gilron;Simon Little;Randy Perrone;Robert Wilt

306
Citations
Spontaneous Pallidal Neuronal Activity in Human Dystonia: Comparison With Parkinson’s Disease and Normal Macaque

Philip A. Starr;Geoff M. Rau;Valerie Davis;William J. Marks

306
Citations
Ablative surgery and deep brain stimulation for Parkinson's disease.

Philip A. Starr;Jerrold L. Vitek;Roy A.E. Bakay

298
Citations